CN Patent

CN1756541A — 包含5－甲基－2－(2′－氯－6′－氟苯氨基)苯乙酸的药物组合物

Assigned to Novartis AG · Expires 2006-04-05 · 20y expired

What this patent protects

本发明提供了适于口服施用的包含5－甲基－2－(2′－氯－6′－氟苯氨基)苯乙酸的含水混悬剂。还提供了制备该组合物的方法和使它们稳定的方法。

USPTO Abstract

本发明提供了适于口服施用的包含5－甲基－2－(2′－氯－6′－氟苯氨基)苯乙酸的含水混悬剂。还提供了制备该组合物的方法和使它们稳定的方法。

Drugs covered by this patent

Lioresal (BACLOFEN)

Patent Metadata

Patent number: CN1756541A
Jurisdiction: CN
Classification: —
Expires: 2006-04-05
Drug substance claim: No
Drug product claim: No
Assignee: Novartis AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.